Profil
Lies Vanneste is currently the Director-Investor Relations at Sequana Medical NV since 2018.
Prior to this, Vanneste worked as the Director-Investor Relations at Ablynx NV.
Aktive Positionen von Lies Vanneste
| Unternehmen | Position | Beginn |
|---|---|---|
| SEQUANA MEDICAL N.V. | Investor Relations Contact | 01.07.2018 |
Ehemalige bekannte Positionen von Lies Vanneste
| Unternehmen | Position | Ende |
|---|---|---|
| ABLYNX | Investor Relations Contact | 01.06.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SEQUANA MEDICAL N.V. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
